From Chapter 3: Vaccine Safety.
According to the established standards of biomedical science, almost all of the industry’s safety trials are fundamentally defective in three critical respects.
Instead of inert placebo, their so-called “control” groups receive either the highly reactive adjuvant or a different vaccine entirely.
The observation period for serious adverse events is very brief, rarely longer than a few days, such that life-threatening autoimmune illnesses, which often take weeks, months, or even years to develop, are automatically excluded from consideration.
Third, the lead investigator is given unlimited authority to determine whether or not the reported adverse events are vaccine- related, based on criteria that are kept secret.The result is that only a vanishingly tiny fraction of the deaths and serious injuries reported by the subjects themselves are considered seriously, let alone actually attributed to the vaccines.
The manufacturers’ unwillingness to specify the criteria used to reject these reports lends further credence to the suspicion that the lead investigator’s rôle is to make sure that the results conform to the manufacturers’ commercial agenda, to promote the vaccine as ideally safe and effective, and even to alter or fabricate the data if necessary. A former drug-company Vice-President recently made it unmistakably clear that this corrupt scenario is actually the Standard Operating Procedure throughout the industry.